US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist
  • 1.630
  • -0.065-3.83%
Close Apr 26 16:00 ET
  • 1.650
  • +0.020+1.23%
Post 19:34 ET
89.61MMarket Cap-3260P/E (TTM)

Vivani Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
26.95%26.97M
-20.19%6.22M
31.23%7.14M
71.35%7M
68.95%6.6M
59.43%21.24M
119.56%7.79M
56.21%5.44M
4.09M
31.33%3.91M
Selling and administrative expenses
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
156.89%1.59M
--884K
115.82%1.23M
-General and administrative expense
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
156.89%1.59M
--884K
115.82%1.23M
Research and development costs
19.75%16.97M
6.35%4.71M
15.08%4.44M
20.64%3.86M
47.63%3.96M
28.79%14.17M
48.81%4.43M
34.55%3.86M
--3.2M
11.35%2.68M
Operating profit
-26.95%-26.97M
20.19%-6.22M
-31.23%-7.14M
-71.35%-7M
-68.95%-6.6M
-59.43%-21.24M
-119.56%-7.79M
-56.21%-5.44M
-4.09M
-31.33%-3.91M
Net non-operating interest income expense
Other net income (expense)
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
114,550.00%6.87M
-16K
-41.67%-17K
Other non- operating income (expenses)
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
114,550.00%6.87M
---16K
-41.67%-17K
Income before tax
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
-4.1M
-31.37%-3.92M
Income tax
Net income
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
-4.1M
-31.37%-3.92M
Net income continuous Operations
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
---4.1M
-31.37%-3.92M
Minority interest income
Net income attributable to the parent company
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
-4.1M
-31.37%-3.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
-4.1M
-31.37%-3.92M
Basic earnings per share
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
137.92%0.04
-0.0809
-31.37%-0.1186
Diluted earnings per share
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
137.92%0.04
-0.0809
-31.37%-0.1186
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 26.95%26.97M-20.19%6.22M31.23%7.14M71.35%7M68.95%6.6M59.43%21.24M119.56%7.79M56.21%5.44M4.09M31.33%3.91M
Selling and administrative expenses 41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M156.89%1.59M--884K115.82%1.23M
-General and administrative expense 41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M156.89%1.59M--884K115.82%1.23M
Research and development costs 19.75%16.97M6.35%4.71M15.08%4.44M20.64%3.86M47.63%3.96M28.79%14.17M48.81%4.43M34.55%3.86M--3.2M11.35%2.68M
Operating profit -26.95%-26.97M20.19%-6.22M-31.23%-7.14M-71.35%-7M-68.95%-6.6M-59.43%-21.24M-119.56%-7.79M-56.21%-5.44M-4.09M-31.33%-3.91M
Net non-operating interest income expense
Other net income (expense) -82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K114,550.00%6.87M-16K-41.67%-17K
Other non- operating income (expenses) -82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K114,550.00%6.87M---16K-41.67%-17K
Income before tax -84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M-4.1M-31.37%-3.92M
Income tax
Net income -84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M-4.1M-31.37%-3.92M
Net income continuous Operations -84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M---4.1M-31.37%-3.92M
Minority interest income
Net income attributable to the parent company -84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M-4.1M-31.37%-3.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M-4.1M-31.37%-3.92M
Basic earnings per share -38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18137.92%0.04-0.0809-31.37%-0.1186
Diluted earnings per share -38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18137.92%0.04-0.0809-31.37%-0.1186
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg